Advanced Medical Solutions Group PLC - Cheshire-based woundcare products firm - Expects adjusted pretax profit for 2020 slightly ahead of market forecasts, though revenue will be slightly below consensus at GBP86.5 million, down 16% from 2019. Adjusted pretax profit in 2019 amounted to GBP26.6 million. AMS said it was hurt by Covid-19 restrictions disrupting "entire global market" and slowing down treatment volumes.
Current stock price: 235.00 pence
Year-to-date change: down 3.3%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Advanced Medical Solutions Group (AMS)